シェアード・リサーチ
Contents
1. _2010 10 PT Tr lt 2010 12 2011 72. symbiosis www sharedresearch jD Shared eseatche 50 52 R Shared Research Report gt
3. VOYAGE GROUP HD
4. CC HMA HMA MDS 2014 8
5. SR Inc SR Inc Shared Research SR Inc lt SR Inc SR Inc
6. 2012 12 2013 12 3 3 77 11 032 122 769 8 164 17 368 140 137 1 216 9 380 1 2011 10 5 100 000 19 130 900 2 628 12 019 2013 3 921 257 23 052 157 1 244 13 263
7. 2005 3 3000 2005 12 Bendamustine Hydrochloride 2006 3 13AZ200010 2007 3 or a SyB L 0501 2008 SyB L 0501 2009 3 SyB L 0501 2009 5 SyB L 0501
8. 2012 6 2016 12 1 2016 12 2017 12 2013 5 1 2016 12 1 2016 12 2017 12
9. R CHOP R B NCCN National Comprehensive Cancer Network ESMO Europe s leading medical oncology society R B
10. J GCA DIC TOKAI
11. 2014 10 2012 6 MDS 2014 2 MDS BSC Best Supportive Care
12. www sharedresearch jD Shared eSeafCh 24 52 R Shared Research Report 4582 gt LAST UPDATE 2015 09 01 1 2012 3 201
13. 2014 MDS 2015 1 2015 MDS MDS 1
14. www sharedresearch jD s Shar eSeafch 18 52 R Shared Research Report 4582 gt LAST UPDATE 2015 09 01 1 3 5 4
15. 1 000 100 3
16. 2005 12 5 2010 10 2010 12 3 2014 12 4 320 57 58 4700 4 500 5 000 2015 8
17. 1 056 1 6 7 1 303 1 681 189 16 8 215 1 110 1 601 1 116 1 605 www sharedresearch jD Shared eseatche 37 52 R Shared Research Report K gt LAST UPDATE 2015 09 01 2014 12 1 2014 2
18. Www sharedresearch jp Shared eSeafCh 17 52 R Shared Research Report 4582 gt LAST UPDATE 2015 09 01 SAB a Sdn ip CMO FDA Robert Lewis iPS 2012
19. 3 4 5 ii 5 i 6 14
20. NHL Non Hodgkin lymphoma Diffuse Large Cell Type www sharedresearch jD Shared eseatche 49 52 R Shared Research Report 4582 gt LAST UPDATE 2015 09 01 PFS Progression Free Survival
21. 2014 10 2015 8 2016 12 1 2015 8 MDS MDS MDS 3 MDS 2015 10
22. SR 80 909 25 5 000 6 000 4 000 5 500 2 700 3 900 SR 2020 12 8500 10 000 3 900 5 100 2020 12 900 2 600 1 000 1 500 SR 500 MR 40
23. SR 10 1 10 1 2013 R amp D 2006 2008 67 46 I 19 77 9096 BIOtechNOW 2004 gt 2011 6 79 12 1 459
24. 4 700 2014 12 4 320 7 100 6 700 700 19 200 4 320 RI 2014 12 7 100 T 2 i IL
25. SAB POC 5 POC POC 2 1 2 5 1 15 gt 20
26. SR Inc SR Inc SR Inc Shared Research inc 3 31 12 http www sharedresearch jDp TEL 03 5834 8787 Email info sharedresearch jp Shared i esearche 52 52 www sharedresearch jD
27. www sharedresearch jD sShared eS atche 30 52 R Shared Research Report 4582 gt LAST UPDATE 2015 09 01 1 500 1 000 1 000 gt 2 000
28. PP 9490 B 6996 T NK 2596 4 2 SR Www sharedresearch jp Shared eSeafCh 21 52 R Shared Research Report 4582 gt LAST UPDATE 2015 09 01 2005 12 1 4503 Astellas Deutschland GmbH 2007 4
29. 3 www sharedresearch jD Shared eseatch 14 52 R Shared Research Report gt LAST UPDATE 2015 09 01 2010 10 2015 8 2016 12 2017 12
30. SR MDS MDS IPSS International Prognostic Scoring System IPSS 1 2 4 MDS 1 MDS 2 www sharedresearch jD Shared eseatche 25 52 R Shared Research Report 4582 gt LAST UPDATE 2015 09 01
31. 2012 iPS
32. MDS ONTIME BSC Best Supportive Care HMA www sharedresearch jD eshared eseatch 36 52 R Shared Research Report 4582 gt LAST UPDATE 2015 09 01 HMA
33. MG Aiming SBS KLab
34. 3 SAB 10C17 1 5 3 5 2015 8 3 2017 12 2 160 3 754 2 557 3 524
35. www sharedresearch jD Shared eseatch 22 52 R Shared Research Report K gt LAST UPDATE 2015 09 01 B 7 100 700 fy kk 2016 12 2017 12 Ko E gt 2 4 700 6 700 1 E 2010 10 2010 12 SR CHOP
36. we 2015 12 4 2016 12 1 2016 12 2016 12 1 2016 12 2017 12 2016 12 2017 12
37. MDS MDS IPSS 1 5 HLA Il
38. MDS MDS 2015 8 MDS MDS 2014 2 MDS BSC Best Supportive Care 299 199 100 BSC
39. HMA 2015 FDA Food and Drug Administration EMA European Medicines Agency SyB C 1101 MDS 2014 8 MDS MDS SyB L 0501
40. www sharedresearch jD Shared eSeafCh 19 52 Shared Research Report 4582 gt LAST UPDATE 2015 09 01 1 2010 10 27 TT 2015 10 B 2010 1 20 2011 5 31
41. MR MR 120 130 30 40 MR SR MR 2020 12 SR 2020 12 2020 12 10 000 12 000 5 000 6 000
42. SR 2020 12 5 000 6 000 SR 2020 12 15 000 18 000 20 000 15 000 300 350 10 000 5 000 15 12 16 12 17 12 18 12 19 12 20 12 SR 2020 12 3 900 5 100 4 75 11 500 4 600 1 200
43. SyB 0501 9 2014 2 II 1 2014 10
44. 47 1 47 Sl Www sharedresearch jp Shared Gcseareh 02 52 R Shared Research Report 4582 gt LAST UPDATE 2015 09 01 POC Proof of Concept POC
45. CC G mmunoglobulin G lgG SPA FDA www sharedresearch jD sShared eS atche 48 52 R Shared Research Report K gt LAST UPDATE 2015 09 01
46. MDS gt p MDS www sharedresearch jD eShat esearch 20 52 R Shared Research Report gt LAST UPDATE 2015 09 01 MDS SyB L 0501 5 SyB L 0501 1971 B
47. 32 20 2013 3 MDS 2015 6 www sharedresearch jD Shared eseatche 28 52 R Shared Research Report 4582 gt LAST UPDATE 2015 09 01 2016 12 2017 12 MDS 7 800 MDS 3 200 9
48. 14 16 NS 20 30 SW Strengths Weaknesses 32 en 33 36 eaccess 40
49. SR 24 oe 75
50. 125 MDS Myelodysplastic Syndromes MDS 30 MDS 10 lt 2096 3 5 10 MDS
51. 2012 7 691 2021 10 614 0 2012 389 2021 602 7 691 105 09 6 1 614 138 0 1 195 112 4 1 994 166 9 389 111 5 602 154 896 2015 8 www sharedresearch jD Shared ese atche 33 52 R Shared Research Report 4582 gt LAST UPDATE 2015 09 01 1 4519 2011 229 2012 247 2013 262 2014 262
52. 1 630 2008 8 1 497 868 09 12 10 12 11 12 12 12 13 12 14 12 Pr 1 933 2 338 1 927 1 785 1 883 OS5 1 532 1 955 2 6 16 4 20 5 9 596 2 351 1 625 1 889 1 654 s 2 067 1 700 1 681 1 303 2 398 1 652 1 922 1 650 2 095 1 729 1 601 1 110 5 2 407 1 656 1 926 1 654 2 105 1 733 1 605 1 116 a a
53. 2009 12 9 553 100 651 727 1 12 2013 12 6 720 200 29 772 357 2 504 15 767 SR www sharedresearch jD 43 52 R Shared Research Report 4582 gt LAST UPDATE 2015 09 01 7 12 2005 3 1980
54. 3 SW Strengths Weaknesses www sharedresearch jD Shared eseatch 03 52 R Shared Research Report gt 4582 LAST UPDATE 2015 09 01 09 12 10 12 11 12 12 12 13 12 14 12 15 12 1 191 26 996 1 191 26 9 100 0 208 1 883 29 8 658 45 7 35 0 2 067 1 532 S10 318 46 49 20 8 1 681 EPS EPS DPS BPS 68 6
55. 3 5 Weaknesses 2014 12 6 600
56. 11 6 51 2 273 30 i 0 4 2 SyB L 0501 SyB L 1101 SyB C 1101 527 0 7 931 Shar eSeafch lt 06 52 www sharedresearch jD R Shared Research Report 4582 gt LAST UPDATE 2015 09 01 648 646 29 35 674 713 676 715 2015 12 2
57. 2 725 49 4 1 945 73 9 SyB D 0701 HSP32 SyB 0702 Shared 8 esearche 40 52 Www sharedresearch jp R Shared Research Report 4582 gt LAST UPDATE 2015 09 01 2010 12 1 450 21 79 326 1 124
58. MDS 2012 6 2015 8 MDS MDS 1 MDS MDS 2013 3 2015 6 MDS 2016 12 MDS MDS 3 200 2019 12
59. 1 5 www sharedresearch jD s Shar eSeafch 11 52 R Shared Research Report K gt LAST UPDATE 2015 09 01 1 2 1 2015 12
60. 2005 B 2 2008 st 2007 2008 3 10 2010 10 2010 12 2015 8 1 2015
61. SR Mr 1 500 1 000 2008 8 SR 5 5 2 2015 8
62. 4230 7 4 1 432 26 8 100 1 053 26 8 946 10 6 1 999 12 9 1 681 1 700 35
63. MDS I 2015 8 FDA 2013 12 ASH American Society of Hematology I MDS 60 1 2 14 7 8 36 14 39
64. 101 112 19 131 19 131 30 634 30 634 32 5 59 3 143 6 90 6 69 3 36 3 402 8 365 4 345 3 254 7 239 5 208 8 4 121 4 016 6 511 4 640 264 6 591 4 218 4 213 7 178 5 421 7 634 7 290 13 22 17 14 9 49 27 27 48 57 37 49 2 1 13 11 8 66 4 261 4 263 7 256 5 502 7 687 7 454 1 309 330 E 306 205 178 646 599 251 488 2 2 5 4 2 207 180 651 602 254 490 4 054 4 083 6 606 4 900 7 433 6 964 RO A ROE SR 211 4 2 963 696 8 196 95 1 54 116 663 15 1 15 8 95 8 2 074 117 4 611 36 596 39 496 91 09 www sharedresearch jD 1 659 411 1 27 29 6 30 29 6 89 1 1 677 992 4 057 24 39 26 396 96 796 1 266 314 544 14 79 15 896 93 4 04 52 R Shared Research Report 4582 gt LAST UPDATE 2015 09 01 2015
65. 2015 2012 6 MDS T 2015 1 2015 10 FDA EMA 2015 12 4 MDS 1 I MDS 2015 8 18 2
66. 1 500 SR 2020 12 900 2 600 www sharedresearch jD sShar eSeafch 13 52 R Shared Research Report 4582 gt LAST UPDATE 2015 09 01 2005 3 5 POC
67. 2011 7 1 800 SR 2012 9 50 565 2015 8 MDS MDS MDS
68. 3 1 1 1 4523 Sientifie Adyimtry Baard SAB SAB 3 POC
69. 2012 6 SyBL 1101 SyBC 1101 rigosertib SyB L 1101 MDS 2015 1 HMA MDS 10 2015
70. www sharedresearch jD Shared eSeafCh 31 52 R Shared Research Report 4582 gt LAST UPDATE 2015 09 01 SW Strengths Weaknesses SR Strengths Weaknesses Strengths PP 1 SAB SAB PP 1
71. 2011 1 MDS DNA 3 6 MDS MDS 2015 3 10 814 11 6 2016 3 11 500 Www sharedresearch jp Shared ese atche 35 52 R Shared Research Report 4582 gt LAST UPDATE 2015 09 01 2015 12 1 2015 12 1 SyB L 0501 408
72. 2008 9 000 2008 2 781 2014 MDS 11 000 MDS 9 1 MDS 1 SR 2015 8 MDS 9 MDS 1 4516 2006
73. 1 870 4 3 2 452 2 481 2 485 1 870 3 6 1 767 20 4 103 78 2 2014 12 1 XA ns a 2014 12 156 2015 12 2015 12 273 2014 12 2014 12 1 823 1 624
74. 7 2014 12 2014 12 1 955 27 6 Ws a 1 940 35 5 1 468 12 9 472 3 6 1 273 15 85 0 1 830 8 4 774 26 5
75. 42 43 44 44 45 47 Uh 47
76. 2014 6 3 Eisai Korea Inc 1 2 2 www sharedresearch jD Shared eseatche 38 52 R Shared Research Report 4582 gt LAST UPDATE 2015 09 01 2013 12 1 532 21 6
77. AMGen Applied Molecular Genetics 1993 5 2008 2 100 2005 1 4568 JASDAQ 4557 1 4282 SBI 1 8473 1 10 2005 12 Ms 2008
78. 2014 2 2014 10 2012 6 SyB L 1101 MDS 2015 1 2014 2
79. 114 1 601 1 729 1 605 1 733 www sharedresearch jD Shared eSeafCh 39 52 1Ecg R Shared Research Report gt LAST UPDATE 2015 09 01 09 12 10 12 11 12 12 12 13 12 14 12 1 191 1 450 1 883 1 955 1 532 1 955 26 9960 21 796 29 896 3 9 21 6 27 696 238 1 224 1 362 1 214 1 428 1 191 1 212 658 593 318 527 100 0 83 6 35 0 30 3 20 8 26 9 1 399 1 825 2 725 2 293 1 999 1 830 117 5 125 8 144 8 117 3 130 4 93 6 208 613 2 067 1 700 1 681 1 303 20 13 56 114 215 26 38 85 37 35 22 214 638 2 095 1 729 1 601 1 110 6 6 2 0 5 0 3 4 4 4 4 4 4 218 642 2 105 1 73
80. KOL Key Opinion Leader 9 CRO Contract Research Organization CON
81. POC Proof of Concept 30 2 000 10 0 3 B
82. 50 2008 12 15 2010 10 2010 12 2014 7
83. 455 715 944 1 116 420 676 2 485 6 14 12 15 12 76 76 cte 174 802 373 607 408 568 64 5 149 1 27 39 6 191 0 135 0 29 2 32 215 106 173 120 162 78 6 543 69 19 8 286 196 272 1 24 5 18 69 26 8 28 5 28 5 29 5 28 6 448 445 427 510 453 478 9 0 10 89 10 1 4 3 1 1 7 3 257 99 55 6 114 5 84 0 110 9 84 1 416 231 320 337 332 316 454 259 228 170 419 255 455 261 228 172 420 256 SR 2015 12 2 2015 12 2 SyB L 0501 0 1 976 1 796
84. OS 8 2 BSC 5 8 P 0 27 299 184 629 OS 8 5 BSC 4 7 P 0 022 60 3 7 3 2015 8 FDA Food and Drug Administration FDA
85. 700 SR 300 lt 350 B R CHOP R CHOP 4 65
86. 2014 6 16 2009 12 30 2011 10 18 MDS I 2015 11 SyB L 1101 MDS 1 SyB C 1101 1 2015 6 SR SR 2015 8
87. 03 5472 1125 2005 3 25 HP http www symbiopharma com index html IR IR www sharedresearch jD Shared 4582 LAST UPDATE 2015 09 01 105 0001 2 2 30 JASDAQO 2011 10 20 12 IR http www symbiopharma com ir index html IR eSeafch 51 52 R Shared Research Report SR SR
88. 2014 262 B CD20 B www sharedresearch jD Shared ese atche 34 52 R Shared Research Report K gt LAST UPDATE 2015 09 01 B 2008 1 2008 8 RI 1 4901 MDS MDS 11 000 60
89. 2015 12 4 Replication Study HMA HMA 2015 12 4 MDS 2015 6 2016 12 MDS
90. 2015 12 2017 12 3 2 300 3 500 2014 12 OT SR Www sharedresearch jp Shared eSeafCh 15 52 R Shared Research Report 4582 gt LAST UPDATE 2015 09 01 5 6
91. 1 SOE gt 7 800 3 200 ek 2 019 2020 12 1 1 1 1 2015 6 2015 10 SR SR MDS MDS IPSS 2 HLA Human Leukocyte Antigen www sharedresearch jD 26 52 R Shared Research Report K gt LAST UPDATE 2015 09 01
92. 646 1998 ICH E5
93. 1 497 2014 12 2016 12 2 3 2 2014 12 1 25 20 100 100 1 666 666 500 000 000 300 Oak VV VV 34 2014 12 1 30 304 www sharedresearch jD Shared eSeafCh 45 52 R Shared Research R
94. 5 2010 12 3 3
95. MR Medical Representative OS Overall Survival Orphan Drug 10
96. 3 10 17 10 1 1 5 3 5 2011 7 Il Onconova Therapeutics Inc 1 2012 9 Baxter International Inc 50 565
97. SyBL 1101 SyB C 1101 2011 10 Symbenda aa SIT 2011 10 JASDAQ 2012 2 Innomustine 2014 11 2014 11 14 2 34 2 34
98. 1 825 30 4 1 118 36 9 SyB D 0701 HSP32 SyB 0702 2009 12 1 191 26 9 1 191 2009 3 2009 10 1 399 6 5 817 5 9 2008 12 1 630 2007 12
99. gt LAST UPDATE 2015 09 01 SAB Scientific Advisory Board SAB 10 400 3 10 400
100. 1993 2005 3 2014 12 69 6 41 10 17 4 10 17 www sharedresearch jD Shared eSeafCh 47 52 R Shared Research Report 4582 LAST UPDATE 2015 09 01 2 3 3 5 3 7 1 T
101. 2015 12 4 2016 12 1 2011 11 I 2015 12 4 2016 12 1 2016 12 7 100 1 5 SR 5 500 6 000
102. 2015 12 2017 12 7 400 9 100 www sharedresearch jD Shared eSeafCh 32 52 R Shared Research Report gt LAST UPDATE 2015 09 01 a
103. 4 2008 8 InnoPharmax Inc Cephalon Inc 2014 12 199 10 8
104. 1 SAB 10 400
105. SyB C 1101 MDS 2015 6 MDS MDS SyB L 0501 www sharedresearch jD Shared eSeafCh 07 52 R Shared Research Report gt LAST UPDATE 2015 09 01 14 12 15 12 Hi SR
106. 135 0 2 1 SyB L 0501 SyB L 1101 SyB C 1101 206 15 2 247 8 3 453 1 1 332 416 89 91 419 454 420 455 2015 12 1 SyBL 0501
107. 2016 12 2017 12 2020 12 2008 12 2008 12 2015 12 ee 2 452 2 481 2 485 2015 12 2017 12 2 300 3 500 SR 2020 12 8 500 10 000 900 gt 2 600
108. 2016 12 2017 12 4 700 SR 4 500 5 000 7100 700 2015 8 SR 6 000 6 500 www sharedresearch jD Shared eseatche 12 52 R Shared Research Report K gt LAST UPDATE 2015 09 01 2020 12
109. 199 2015 12 1 987 1 611 376 9 0 I 1 886 2014 12 774 A 2 999 1 829 Www sharedresearch jp Shared ese atche 08 52 R Shared Research Report 4582 gt LAST UPDATE 2015 09 01 9 2015 12 2015 12 4 2016 12 1
110. POC POC OE _ www sharedresearch jD sSharedd eSeafch 16 52 R Shared Research Report 4582
111. 2 3 4 www sharedresearch jD Shared eseatche 27 52 R Shared Research Report 4582 gt LAST UPDATE 2015 09 01 18 9 2015 8 MD 3 1 MDS 2015 6 MDS 2016 12 2017
112. 2010 9 Symbenda www sharedresearch jD Shared eSeafCh 44 52 R Shared Research Report K gt LAST UPDATE 2015 09 01
113. SR 2015 8 B IDEC Pharmaceuticals Corp Biogen Idec Inc Genentech inc 1997 11 lgG B CD20 SR 2001 9
114. 2010 23 919 60 18 240 76 3 2000 2010 80 2012 a 21 100 2015 2019 23 000 2020 2024 24 500 30 000 25 000 20 000 15 000 10 000 1975 1980 1985 1990 1995 2000 2005 2010 5 000 1975 1980 1985 1990 1995 2000 2005 2010 4 013 4 741 6 635 9 297 11 195 13 307 16 991 23 919 10 3 6 4 1 5 5 7 5 8 9 10 5 13 3 18 7 SR
115. 1 4516 MDS 2014 3 9 692 38 1 2015 3 10 800 SR www sharedresearch jD Shared eSeafCh 29 52 R Shared Research Report gt LAST UPDATE 2015 09 01 08 12 09 12 10 12 11 12 12 12 13 12 14 12 1 630 1 191 1 450 1 883 1 955 1 532 1 955 326 1 632 1 955 1 432 1 940 644 3 390 3 940 4 230 4 320 50 6 48 2 49 6 33 9 44 9 1 630 1 191 1 124
116. 2015 12 4 2016 12 1 2016 12 1 2015 SR 2015 5 2020 12 900 lt 2 600 SR 3
117. 2 6 1 2 1 1 1 59 BNYM SA NV for BNYM Client Account MPCS Japan 1 396 1 296 0 8 SR SR 2014 12 1971 MIT MIT T4 1975 1977 1980
118. 2011 3 2012 3 2015 8 BfArM Bundesinstitut far Arzneimittel und Medizinprodukte 2015 12 3 81 2003 9 2008 8 IV R CHOP R B R B 274 R CHOP 275 45 PFS R B 69 5 R CHOP 31 2 p lt 0 0001 p 5 R B www sharedresearch jD 23 52 R Shared Research Report gt LAST UPDATE 2015 09 01
119. 2014 11 6 Il SyB L 0501 2010 10 2010 12 100mg www sharedresearch jD Shared eSeafCh 46 52 R Shared Research Report 4582 LAST UPDATE 2015 09 01 10 9 6 8 0 V2 5 7 Oak 5 1
120. 1 MDS MDS 2016 12 2017 12 2015 12 1 2015 8 2 www sharedresearch jD sSharedd eSeafch 09 52 R Shared Research Report 4582 gt LAST UPDATE 2015 09 01 2 www sharedresearch jD Shared eSeafCh 10 52 R Shared Research Report gt LAST UPDATE 2015 09 01 2014 12 2015
121. 9 1 2015 8 5 2015 12 2 2015 12 2 3 amp www sharedresearch jD Shared eseatch 05 52 R Shared Research Report gt 4582 LAST UPDATE 2015 09 01 14 12 15 12 15 12 6 Plcb EE 76 Pc16 pe cte 174 975 1 348 1 955 408 976 52 2 1 870 64 5 20 3 1 9 27 6 135 0 0 1 122 1 32 247 353 527 120 283 78 69 34 1 29 4 65 6 272 1 14 396 18 69 25 3 26 2 26 9 29 5 28 9 448 893 1 320 1 830 453 931 9 0 9 9 10 09 8 4 1 1 4 2 257 9 91 6 97 9 93 6 110 9 95 3 416 646 967 1 303 332 648 2 452 454 713 941 1 110 419 674 2 481
122. 10 0 2015 12 4 2016 12 1 2016 12 2016 12 1 2016 12 2017 12 4 70 80 B 20 30 T NK A RE
123. 12 2017 12 3 14 12 15 12 16 12 17 12 1 955 1 870 2919 2 148 3 754 2 160 1 303 2 452 2 390 3 005 2 525 3 492 1 110 2 481 2 419 3 034 2 554 3 521 1 115 2 485 2 422 3 038 2 557 3 524 15 12 16 12 17 12 18 12 19 12 20 12 2 OO MDS MDS MDS SR SR
124. 22 27 50 4 263 124 52 178 M D 180 4 083 3 711 3 681 3 309 4 083 5 2 314 4 559 1 953 162 207 297 7 178 32 22 17 48 10 13 78 7 256 309 278 59 646 UO 651 6 606 6 025 5 995 5 413 6 606 61 4 559 12 12 13 12 5 502 330 196 73 599 602 4 873 6 025 5 995 7 146 27 4 900 17 4 540 a 6 163 1 100 125 245 7 634 34 33 37 53 7 687 207 44 251 CO ww 254 7 336 8 059 8 029 8 752 97 7 433 125 6 163 www sharedresearch jD 4582 14 12 5 692 899 273 426 7 290 22 47 20 49 49 62 66 164 7 454 306 143 39 488 M
125. D 490 6 764 8 331 8 301 9 868 200 6 964 33 5 692 LAST UPDATE 2015 09 01 Shared eSeafch 42 52 R Shared Research Report 4582 gt LAST UPDATE 2015 09 01 09 12 10 12 11 12 12 12 13 12 14 12 e 211 754 2 074 1 659 1 677 1 266 2 4 116 117 411 332 314 FCF 1 2 215 870 2 191 2 069 3 010 952 2 963 663 4 611 4 057 544 A 4 7 8 9 8 13 B 3 14 12 3 109 C 5 56 78 142 159 FCF NI A B C 217 655 2 165 1 650 1 739 1 053 4 121 3 916 6 311 4 240 5 294 5 092 SR
126. 250 100 15 1600 1 085 1 446 1 872 1 930 1 486 1 908 30 106 4 10 26 46 47 238 1 224 1 362 1 214 1 428 73 1 75 0 69 7 84 8 73 6 37 0 36 1 34 6 28 7 33 1 238 1 434 1 322 1 175 1 550 1 630 1 191 1 212 658 593 318 527 1 497 1 399 1 825 2 725 2 293 1 999 1 830 252 323 343 365 413 441 479 868 817 1 118 1 945 1 438 1 053 774 377 259 364 415 442 505 577 133 208 613 2 067 1 700 1 681 1 303 SR 2008 12 rl 8 2010 10 2010 12 PR
127. SR 2011 10 2011 12 www sharedresearch jD Shared eSeafCh 41 52 R Shared Research Report 7 SR gt 09 12 3 902 219 97 4 218 18 12 13 27 42 4 261 182 23 205 M D 207 4 060 3 378 3 348 2 666 4 054 3 902 10 12 11 12 2 314 1 701 191 4 213 31 16
128. 2 5 PMDA Pharmaceutical and Medical Devices Agency PMDA PMDA 6 700 SyB L 1101 SyB C 1101 Onconova Therapeutics Inc MDS Myelodysplastic Syndromes MDS 1998
129. 3 1 605 1 116 SR 2012 12 1 955 3 9 19 8 3 940 16 2 2 293 15 8 1 438 26 1 i 2011 12 1 883 29 8 1 632 401 3 3 390 2010 12 64 250
130. LAST UPDATE 2015 09 01 4582 Research Report by Shared Research Inc sr_inquiries sharedresearch jp R Shared Research Report 4582 LAST UPDATE 2015 09 01
131. eport K gt LAST UPDATE 2015 09 01 10 363 968 1 342 3 030 400 1 010 395 968 10 363 968 1 000 032 000 330 Oak yy yy Vy 2014 11 13 2014 12 2014 12 gt 1 990 1 785 1 311 1654 1 308 1 650 p 1 311 1 654 2014 12 Pe 1 990
Download Pdf Manuals
Related Search